Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Fidler

Showing results (171-180 of 288) with videos related to

Pageof 29
Sort By:
HIV Medicine|April 16, 2026
Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ARTMerle Henderson, Peter Dutey-Magni, Carolina Herrera, et al.
AIDS (London, England)|December 22, 2023
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recoveryJohn Patrick Thornhill, Julie Fox, Genevieve Elizabeth Martin, et al.
The Journal of Clinical Investigation|January 26, 2005
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral reboundThomas J Scriba, Hua-Tang Zhang, Helen L Brown, et al.
Plos One|April 20, 2018
Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South AfricaPeter Bock, Geoffrey Fatti, Nathan Ford, et al.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
Journal of the International AIDS Society|August 29, 2023
Community- and individual-level correlates of HIV incidence in HPTN 071 (PopART)Timothy Skalland, Helen Ayles, Peter Bock, et al.
AIDS (London, England)|October 24, 2013
A systematic review of definitions of extreme phenotypes of HIV control and progressionDeepti Gurdasani, Louise Iles, David G Dillon, et al.
PLOS Global Public Health|June 20, 2025
Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South AfricaMaria Ruperez, Jacob Busang, Linda Mureithi, et al.
The Lancet. Global Health|April 15, 2023
Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South AfricaMaria Ruperez, Kwame Shanaube, Linda Mureithi, et al.
The Journal of Infectious Diseases|June 20, 2012
Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infectionHongbing Yang, Hao Wu, Gemma Hancock, et al.
Pageof 29

Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
HIV Medicine|April 16, 2026
Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ARTMerle Henderson, Peter Dutey-Magni, Carolina Herrera, et al.
AIDS (London, England)|December 22, 2023
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recoveryJohn Patrick Thornhill, Julie Fox, Genevieve Elizabeth Martin, et al.
The Journal of Clinical Investigation|January 26, 2005
HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral reboundThomas J Scriba, Hua-Tang Zhang, Helen L Brown, et al.
Plos One|April 20, 2018
Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South AfricaPeter Bock, Geoffrey Fatti, Nathan Ford, et al.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
Journal of the International AIDS Society|August 29, 2023
Community- and individual-level correlates of HIV incidence in HPTN 071 (PopART)Timothy Skalland, Helen Ayles, Peter Bock, et al.
AIDS (London, England)|October 24, 2013
A systematic review of definitions of extreme phenotypes of HIV control and progressionDeepti Gurdasani, Louise Iles, David G Dillon, et al.
PLOS Global Public Health|June 20, 2025
Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South AfricaMaria Ruperez, Jacob Busang, Linda Mureithi, et al.
The Lancet. Global Health|April 15, 2023
Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South AfricaMaria Ruperez, Kwame Shanaube, Linda Mureithi, et al.
The Journal of Infectious Diseases|June 20, 2012
Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infectionHongbing Yang, Hao Wu, Gemma Hancock, et al.
Pageof 29